Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

Christophe Mannaerts; Marc Engelbrecht; Arnoud Postema; Olivia Lodeizen; Rob van Kollenburg; Ruud van Sloun; Rogier Wildeboer; Massimo Mischi; Theo de Reijke; Hessel Wijkstra

doi:10.1097/01.JU.0000557571.17930.bb

Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?

Christophe Mannaerts (Corresponding author)
, Marc Engelbrecht
, Arnoud Postema
, Olivia Lodeizen
, Rob van Kollenburg
, Ruud van Sloun
, Rogier Wildeboer
, Massimo Mischi
, Theo de Reijke
, Hessel Wijkstra

Onderzoeksoutput: Bijdrage aan tijdschrift › Congresartikel › peer review

Samenvatting

Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.

Originele taal-2	Engels
Pagina's (van-tot)	e430-e430
Aantal pagina's	1
Tijdschrift	Journal of Urology
Volume	201
Nummer van het tijdschrift	4S
DOI's	https://doi.org/10.1097/01.JU.0000557571.17930.bb
Status	Gepubliceerd - 1 apr. 2019
Evenement	114th American Urological Association Annual Meeting - Chicago, Verenigde Staten van Amerika Duur: 3 mei 2019 → 6 mei 2019 http://www.aua2019.org/

Duurzame ontwikkelingsdoelstellingen van de VN

Deze output draagt bij aan de volgende duurzame ontwikkelingsdoelstelling(en)

SDG 3 – Goede gezondheid en welzijn

Toegang tot document

10.1097/01.JU.0000557571.17930.bb

Citeer dit

Mannaerts, C., Engelbrecht, M., Postema, A., Lodeizen, O., van Kollenburg, R., van Sloun, R., Wildeboer, R., Mischi, M., de Reijke, T., & Wijkstra, H. (2019). Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy? Journal of Urology, 201(4S), e430-e430. https://doi.org/10.1097/01.JU.0000557571.17930.bb

@article{dc9e0e03b7a4451bbcb6918552e7ca87,

title = "Multiparametric mri- and contrast enhanced ultrasound-targeted biopsy for the detection of significant prostate cancer: can we replace systematic biopsy?",

abstract = "Contrast-enhanced ultrasound (CEUS) with quantitative parametric imaging is currently not recommended for the detection of prostate cancer (PCa). Meanwhile, multiparametric magnetic resonance imaging (mpMRI)-targeted biopsy (TBx) has evolved as an alternative to systematic transrectal ultrasound (TRUS)-guided biopsy (SBx). However, mpMRI before first biopsy remains controversial. In this prospective trial, we compared clinically significant (cs)PCa detection rates for MRI-TBx and CEUS-TBx with standard SBx in biopsy-naive men.",

author = "Christophe Mannaerts and Marc Engelbrecht and Arnoud Postema and Olivia Lodeizen and \{van Kollenburg\}, Rob and \{van Sloun\}, Ruud and Rogier Wildeboer and Massimo Mischi and \{de Reijke\}, Theo and Hessel Wijkstra",

year = "2019",

month = apr,

day = "1",

doi = "10.1097/01.JU.0000557571.17930.bb",

language = "English",

volume = "201",

pages = "e430--e430",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Wolters Kluwer Health",

number = "4S",

note = "114th American Urological Association Annual Meeting , AUA2019 ; Conference date: 03-05-2019 Through 06-05-2019",

url = "http://www.aua2019.org/",

}